Takeda Pharmaceutical Company Limited Finance Income
Takeda Pharmaceutical Company Limited (TKPHF) reported Finance Income of JPY 46.55 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2025-06-25
| Period end | Finance Income 12 month |
|---|---|
| 2025-03-31 | 46.55B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 52.09B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 62.91B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 23.70B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 105.52B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 27.83B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 16.84B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 39.54B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 12.27B JPY 20-F · filed 2019-06-27 |